The target blood pressure ( < 130/80 mm Hg ) was achieved in nearly 80 % of the patients taking olmesartan and 71 % taking placebo ; blood pressure measured in the clinic was lower by 3.1 / 1.9 mm Hg in the olmesartan group than in the placebo group .
